KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other financing activities (2016 - 2025)

Gilead Sciences' Other financing activities history spans 17 years, with the latest figure at -$63.0 million for Q4 2025.

  • For Q4 2025, Other financing activities fell 34.04% year-over-year to -$63.0 million; the TTM value through Dec 2025 reached -$440.0 million, down 56.58%, while the annual FY2025 figure was -$440.0 million, 56.58% down from the prior year.
  • Other financing activities reached -$63.0 million in Q4 2025 per GILD's latest filing, up from -$137.0 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of -$6.0 million in Q2 2021 to a low of -$176.0 million in Q1 2025.
  • Average Other financing activities over 5 years is -$65.9 million, with a median of -$55.0 million recorded in 2024.
  • The largest YoY upside for Other financing activities was 21.43% in 2021 against a maximum downside of 700.0% in 2021.
  • A 5-year view of Other financing activities shows it stood at -$11.0 million in 2021, then crashed by 109.09% to -$23.0 million in 2022, then tumbled by 47.83% to -$34.0 million in 2023, then plummeted by 38.24% to -$47.0 million in 2024, then crashed by 34.04% to -$63.0 million in 2025.
  • Per Business Quant, the three most recent readings for GILD's Other financing activities are -$63.0 million (Q4 2025), -$137.0 million (Q3 2025), and -$64.0 million (Q2 2025).